Stanniocalcin 1 and 1,25-dihydroxyvitamin D₃ cooperatively regulate bone mineralization by osteoblasts

Area of Science:

• Endocrinology
• Bone Biology
• Mineral Metabolism

Background:

• Stanniocalcin 1 (STC1) is a hormone regulating calcium and phosphate homeostasis.
• STC1 is expressed in bone tissues and its expression is increased by 1,25-dihydroxyvitamin D3 in renal cells.
• The role of STC1 in osteoblast differentiation and bone homeostasis remains to be fully elucidated.

Purpose of the Study:

• To investigate the direct effects of STC1 on osteoblast differentiation.
• To determine if STC1 reciprocally controls the effects of 1,25-dihydroxyvitamin D3 on osteoblasts.
• To elucidate the contribution of STC1 to bone homeostasis.

Main Methods:

• In vitro studies assessing osteoblast differentiation.
• In vivo studies of bone morphogenetic protein 2 (BMP2)-induced ectopic bone formation.
• Analysis of STC1 expression and its regulation by 1,25-dihydroxyvitamin D3 via the vitamin D receptor (VDR).
• Investigation of STC1's effect on VDR signaling, Akt phosphorylation, and receptor activator of nuclear factor-κB ligand (RANKL) secretion.
• Phenotypic analysis of osteoblast-specific STC1 transgenic mice.

Main Results:

• STC1 inhibited osteoblast differentiation in vitro and BMP2-induced ectopic bone formation in vivo.
• 1,25-dihydroxyvitamin D3 increased STC1 expression by direct binding to the Stc1 promoter via VDR.
• STC1 upregulated VDR expression, inhibited Akt phosphorylation, and enhanced 1,25-dihydroxyvitamin D3-induced RANKL secretion.
• STC1 transgenic mice showed no significant long-bone phenotype, but 1,25-dihydroxyvitamin D3 administration decreased bone mass compared to wild-type mice.
• STC1's inhibitory effect on osteoblasts was transient under normal conditions.

Conclusions:

• STC1 negatively regulates osteoblast differentiation and bone formation.
• STC1 and 1,25-dihydroxyvitamin D3 exhibit a synergistic effect that reduces bone mass by inhibiting osteoblast differentiation.
• These findings highlight a complex interplay between STC1 and vitamin D in regulating bone homeostasis.